Shopping Cart
- Remove All
- Your shopping cart is currently empty
Withanolide B, a natural product isolated from Withania somnifera Dunal, promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) via the ERK1/2 and Wnt/β-catenin signalling pathways, thereby enhancing bone healing. Withanolide B exhibits affinity for the catalytic domain of PARP-1.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $332 | 6-8 weeks | |
5 mg | $932 | 6-8 weeks | |
10 mg | Inquiry | 6-8 weeks |
Description | Withanolide B, a natural product isolated from Withania somnifera Dunal, promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) via the ERK1/2 and Wnt/β-catenin signalling pathways, thereby enhancing bone healing. Withanolide B exhibits affinity for the catalytic domain of PARP-1. |
Targets&IC50 | SK-N-SH cells:14.84±1.45 μM |
In vitro | Methods: SK-N-SH cells were treated with Withanolide B (10-100 μM, 48 hours), and cell viability was assessed using the MTT assay. Results: The IC50 value of Withanolide B for SK-N-SH cells was 14.84±1.45 μM, indicating that Withanolide B exhibits low toxicity to neuronal cells. [1] |
In vivo | Methods: By injecting Withanolide B (10 mg/kg) into the bone defect site of the SD rat tibial osteotomy model, the effect of Withanolide B on the osteogenic differentiation of hBMSCs was investigated. Results: Micro-CT scanning and histological analysis demonstrated that Withanolide B significantly promoted the healing of bone defects. [2] |
Molecular Weight | 454.6 |
Formula | C28H38O5 |
Cas No. | 56973-41-2 |
Smiles | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H]4O[C@@H]4[C@@]4(O)CC=CC(=O)[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)[C@@]1([H])CC(C)=C(C)C(=O)O1 |
Relative Density. | 1.31g/cm3 |
Color | White |
Appearance | Solid |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
Solubility Information | Acetone: 0.8 mg/mL (1.76 mM), Sonication is recommended. DMSO: 2.5 mg/mL (5.5 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
Acetone/DMSO
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.